Brief: Epigenomics FY Net Loss Narrows To EUR 11.7 Million
25/03/2021 10:01
March 25 (Reuters) - EPIGENOMICS AG ECXn.DE :
* REPORTS FINANCIAL RESULTS FOR FISCAL YEAR 2020
* FY NET LOSS -11.7 MILLION EUR VERSUS -17 MILLION EUR LOSS
YEAR
AGO
* FY REVENUE 840,000 EUR VERSUS 1.1 MILLION EUR YEAR AGO
* FY EPS LOSS 2.02 EUR VERSUS 3.65 EUR LOSS YEAR AGO
* OUTLOOK 2021: EXPECTS REVENUE TO BE WITHIN RANGE OF EUR
0.4
MILLION TO EUR 1.0 MILLION
* OUTLOOK 2021: EBITDA RANGE OF EUR -7.0 MILLION TO EUR -9.0
MILLION
Source text for Eikon: ID:nEQ56TBtca
Further company coverage: ECXn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns